Scientific Program
Scientific Program
| Thursday, May 16, 2024 | |
|---|---|
| 09:00 | Welcome address Samir Hamamah, France, Milton Leong, Hong Kong and Zeev Shoham, Israel |
| 09:00-10:00 | Session 1: Striving to improve Controlled Ovarian Stimulation in ART: Should IVM be an alternative? Chairs: Samir Hamamah, France, Milton Leong, Hong Kong and Zeev Shoham, Israel |
| 09:00-09:30 | Mechanisms regulating human oocyte maturation in vitro are different from those active in vivo during the mid-cycle surge Claus Yding Andersen, Denmark |
| 09:30-10:00 | The primordial pool: effect of age and culture conditions Evelyn Telfer, UK |
| 10:00-11:00 | Session 2: Fertility preservation Chairs: Claus Yding Andersen, Denmark, Jacques Donnez, Belgium |
| 10:00-10:30 | Ovarian tissue and fertility preservation: challenging issues and future research Marie Madeleine Dolmans, Belgium |
| 10:30-11:00 | Xenotransplantation of human ovarian tissue in a large animal – a novel model Dror Meirow, Israel |
| 11:00-11:30 | Coffee break |
| 11:30-12:00 | Session 3: Keynote lecture Chairs: Samir Hamamah, France, Milton Leong, Hong Kong and Zeev Shoham, Israel This session is dedicated to celebrating 80 years of Prof. Milton Leong and 50 years of his dedication to medicine, infertility treatment, and research activities |
| 11:30-12:00 | Awareness and fertility education: Toward a worldwide strategy Samir Hamamah, France |
| 12:00-13:00 | Session 4: Medical & No medical Fertility preservation in the true life – Cancer Theramex Sponsored session Chairs: Louise Denjean, France, Jean Marc Ayoubi, France |
| The physician’s point of view Michael Grynberg, France |
|
| The oncologist’s point of view Michael Grynberg, France |
|
| Discussion | |
| 13:00-14:00 | Lunch |
| 14:00-15:30 | Session 5: Revisiting PGTA Chairs: Sherman Silber, USA, Robert Fischer, Germany |
| 14:00-14:30 | Is polar Body Genetic Testing for aneuploidy helpful? Robert Fischer, Germany |
| 14:30-15:00 | Is cell-free DNA analysis in culture media the way to go for aneuploidy testing? Luis Navarro, Spain |
| 15:00-15:30 | Do we need aneuploidy testing in ART? Norbert Gleicher, USA |
| 15:30-16:00 | Coffee break |
| 16:00-17:00 | Session 6: Medical & No medical Fertility preservation in the true life – Societal Theramex Sponsored session Chair: Mathilde Bourdon , France |
| Prevention Nathalie Massin, France |
|
| Simplifying the care pathway in societal prevention Charlotte Sonigo, France |
|
| 17:00-17:30 | Session 7: Medical & No medical Fertility preservation in the true life – Gamete fate Theramex Sponsored session Chair: Tal Anahory, France |
| 17:00-17:30 | Cryopreserved oocytes’ fate Chadi Yazbeck, France |
| 17:30-18:00 | Session 8: Endometriosis, adenomyosis, and infertility Chair: Marie-Madeleine Dolmans, Belgium |
| 17:30-18:00 | Decoding the mechanisms of endometriosis and adenomyosis-related infertility Jacques Donnez, Belgium |
| 18:00-19:00 | Welcome reception |
| Friday, May 17, 2024 | |
|---|---|
| 09:00-10:30 | Session 9: Innovative treatments for reproductive health Chairs: Jean-Marc Ayoubi, France, Milton Leong, Hong Kong |
| 09:00-09:30 | Ovary Transplantation for Turners Syndrome and Robust IVM From Ovary Tissue Sherman Silber, USA |
| 09:30-10:00 | Successful transformation of human somatic ( skin ) cells in vitro to normal germ cells Amander Clark, USA |
| 10:00-10:30 | Reconstruction of Ovary and Testis Using Pluripotent Stem Cells Katsuhiko Hayashi, Japan |
| 10:30-11:00 | Coffee break |
| 11:00-11:30 | Session 10: Keynote lecture Chair: Zeev Shoham, Israel |
| 11:00-11:30 | Patients today are benefitting from stem cells and gene therapies Gerald Schatten, USA |
| 11:30-13:00 | Session 11: Embryo and Oocyte selection issuing Artificial Intelligence (AI) Chairs: Norbert Gleicher, USA, Ariel Weissman, Israel |
| 11:30-12:00 | The use of AI for embryo and oocyte selection Lorena Bori, Spain |
| 12:00-12:20 | AI in reproduction “the clinician perspective” Ariel Hourvitz, Israel |
| 12:20-13:00 | Non-invasive AI-based decision tools and robotics in the IVF laboratory Nikica Zaninovic, USA |
| 13:00-14:00 | Lunch |
| 14:00-16:00 | Session 12: Advancing mitochondrial donation therapies, AMH screening, and follicular maturation Chair: Claus Yding Andersen, Denmark |
| 14:00-15:00 | From Science to Clinical Application: Mitochondrial Donation Therapies – Pre-Translation to Post-Translation, Where Are We Now? Meenakshi Choudhary, UK |
| 15:00-15:30 | Should AMH screening become standard for young, healthy females? Ariel Weissman, Israel |
| 15:30-16:00 | Triggering Final Follicular Maturation – hCG, GnRH-agonist, or Both: When and to Whom? Raoul Orvieto, Israel |
| 16:00-16:30 | Coffee break |
| 16:30-17:30 | Session 13: A combined session for OC and CoGEN Chairs: Samir Hamamah, France, Yuval Yaron, Israel |
| 16:30-17:00 | Ex utero embryogenesis: Naïve pluripotent stem-cell-derived embryoid models (SEMs) Yaqub Hanna, Israel |
| 17:00-17:30 | To the Future… and Beyond! Gerald Schatten, USA |
| 17:30 | Closing remarks Samir Hamamah, France, Milton Leong, Hong Kong and Zeev Shoham, Israel, Yuval Yaron, Israel |